Sanofi Consumer Healthcare India Ltd
Unaudited Financial Results for the quarter and half year ended June 30, 2026 is enclosed.
RESULTS
▲ Positive Development
LOW RISK
📅 Filed on BSE: 28 Jul 2026, 07:52 PM IST · BSE ID: f01b2642-c346-4f56-b47f-ee179b515864
View Original BSE Filing (PDF)
💡
In Simple Terms
Sanofi Consumer Healthcare India Ltd reported a profit of Rs. 688 Million and sales of Rs. 2,357 Million for the recent quarter.
🤖 AI Summary
- Board approved unaudited financial results for the quarter and half year ended June 30, 2026.
- Profit for Q1 FY27 was Rs. 688 Million, with Revenue from Operations at Rs. 2,357 Million.
- Half year ended June 30, 2026, profit was Rs. 1,366 Million and revenue Rs. 4,649 Million.
- Basic and diluted earnings per share for the quarter were Rs. 29.87.
- Total assets as of June 30, 2026, were Rs. 7,064 Million, compared to Rs. 5,470 Million on Dec 31, 2025.
🔢 Key Numbers — exact figures from BSE filing, not rounded
Profit for the period /year (Q1 FY27)
688 Million
13.34%
Revenue from Operations (Q1 FY27)
2,357 Million
6.70%
Profit for the period /year (Half year ended June 30, 2026)
1,366 Million
23.40%
Revenue from Operations (Half year ended June 30, 2026)
4,649 Million
18.15%
Basic and diluted earnings per share (Q1 FY27)
29.87 ₹
13.32%
🏢 How This Affects the Company
Revenue from Operations for Q1 FY27 reached Rs. 2,357 Million, compared to Rs. 2,209 Million in the prior corresponding quarter.
Profit for the period was Rs. 688 Million for Q1 FY27, compared to Rs. 607 Million in Q1 FY26, indicating improved profitability. Cash and cash equivalents increased to Rs. 4,902 Million as of June 30, 2026, from Rs. 3,748 Million on December 31, 2025.
👥 What This Means For Shareholders
✅
Action Required
No immediate action is required by shareholders based on this financial results filing.
👤
Who Is Affected
Shareholders are affected by the company's financial performance, with Basic and diluted earnings per share for the quarter rising to Rs. 29.87 from Rs. 26.36 in the prior comparable quarter.
🔍
Management Signal
Management's approval of the unaudited financial results signals regular compliance and reporting of financial performance.
For information only. Not investment advice. ForgeUp is not SEBI-registered.
👁 Watch List — track these upcoming events
Q2 FY27 financial results — check if revenue growth sustains above Rs. 2,300 Million
Any updates on changes in inventories and employee benefits expense trends
Next Board Meeting outcome for further strategic or financial decisions
LOW RISK
The filing indicates consistent financial performance and growth in key metrics.
💡 Investor Takeaway
Sanofi Consumer Healthcare India Ltd reported a Profit for the period of Rs. 688 Million for the quarter ended June 30, 2026, an increase from Rs. 607 Million in the corresponding prior year quarter. Revenue from Operations for the quarter was Rs. 2,357 Million, up from Rs. 2,209 Million.
⚖️ Strengths & Concerns
✅ Positives
- Profit for the quarter ended June 30, 2026, increased to Rs. 688 Million from Rs. 607 Million in the prior corresponding quarter.
- Revenue from Operations for the half year ended June 30, 2026, grew to Rs. 4,649 Million from Rs. 3,935 Million in the prior corresponding half year.
⚠️ Concerns
- Cost of Materials Consumed for the quarter ended June 30, 2026, was Rs. 475 Million, up from Rs. 402 Million in the previous quarter.
- Total current liabilities increased to Rs. 3,271 Million as of June 30, 2026, from Rs. 1,284 Million on December 31, 2025.
📅 Company Track Record
Sanofi Consumer Healthcare India Ltd reported full-year FY26 profit of Rs. 2,401 Million. Q4 FY26 saw domestic sales recover by 15.5% following product relaunches, contributing to a Q4 profit of Rs. 678 Million. The current Q1 FY27 results show continued growth.
Based on publicly available historical data. For context only.
❓ Frequently Asked Questions
What was Sanofi Consumer Healthcare India Ltd's profit for the quarter ended June 30, 2026?
Sanofi Consumer Healthcare India Ltd reported a Profit for the period of Rs. 688 Million for the quarter ended June 30, 2026.
What was Sanofi Consumer Healthcare India Ltd's Revenue from Operations for Q1 FY27?
The Revenue from Operations for Sanofi Consumer Healthcare India Ltd for the quarter ended June 30, 2026 (Q1 FY27) was Rs. 2,357 Million.
What were the earnings per share for Sanofi Consumer Healthcare India Ltd for the quarter ended June 30, 2026?
Basic and diluted earnings per share for Sanofi Consumer Healthcare India Ltd were Rs. 29.87 for the quarter ended June 30, 2026.
What was Sanofi Consumer Healthcare India Ltd's total income for the half year ended June 30, 2026?
Sanofi Consumer Healthcare India Ltd's total income for the half year ended June 30, 2026, was Rs. 4,768 Million.
How did Sanofi Consumer Healthcare India Ltd's total assets change as of June 30, 2026?
Total assets for Sanofi Consumer Healthcare India Ltd increased to Rs. 7,064 Million as of June 30, 2026, from Rs. 5,470 Million as of December 31, 2025.
Questions based on this BSE filing only. For information purposes.